High on‐aspirin platelet reactivity as measured with aggregation‐based, cyclooxygenase‐1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events
- 1 October 2010
- journal article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 8 (10), 2140-2148
- https://doi.org/10.1111/j.1538-7836.2010.04017.x
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Incidence and Clinical Impact of Dual Nonresponsiveness to Aspirin and Clopidogrel in Patients With Drug-Eluting StentsJournal of the American College of Cardiology, 2008
- Use of the PFA-100™ closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysisJournal of Thrombosis and Haemostasis, 2008
- Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysisBMJ, 2008
- Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapyPlatelets, 2008
- Resistance to antiplatelet drugs: molecular mechanisms and laboratory detectionJournal of Thrombosis and Haemostasis, 2007
- Evaluation of Dose-Related Effects of Aspirin on Platelet FunctionCirculation, 2007
- A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery diseaseEuropean Heart Journal, 2007
- Impact – The Cone and Plate(let) Analyzer: Testing Platelet Function and Anti-Platelet Drug ResponsePathophysiology of Haemostasis and Thrombosis, 2006
- Aspirin and Clopidogrel Drug Response in Patients Undergoing Percutaneous Coronary Intervention: The Role of Dual Drug ResistanceJournal of the American College of Cardiology, 2006
- Aspirin resistance: position paper of the Working Group on Aspirin ResistanceJournal of Thrombosis and Haemostasis, 2005